$EKSO
EKSO BIONICS HOLDINGS, INC.

2020 Q2 Form 10-Q Financial Statement

#000154908420000025 Filed on July 30, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $2.264M $3.262M
YoY Change -30.59% 9.94%
Cost Of Revenue $1.005M $1.702M
YoY Change -40.95% -14.9%
Gross Profit $1.259M $1.560M
YoY Change -19.29% 61.32%
Gross Profit Margin 55.61% 47.82%
Selling, General & Admin $3.655M $5.159M
YoY Change -29.15% -23.68%
% of Gross Profit 290.31% 330.71%
Research & Development $452.0K $1.499M
YoY Change -69.85% 7.92%
% of Gross Profit 35.9% 96.09%
Depreciation & Amortization $160.0K $240.0K
YoY Change -33.33% -47.83%
% of Gross Profit 12.71% 15.38%
Operating Expenses $4.351M $6.658M
YoY Change -34.65% -18.33%
Operating Profit -$3.092M -$5.098M
YoY Change -39.35% -29.05%
Interest Expense $38.00K $107.0K
YoY Change -64.49% -33.13%
% of Operating Profit
Other Income/Expense, Net -$8.675M $2.032M
YoY Change -526.92% -356.24%
Pretax Income -$11.77M -$3.070M
YoY Change 283.39% -61.53%
Income Tax
% Of Pretax Income
Net Earnings -$11.77M -$3.066M
YoY Change 283.79% -61.57%
Net Earnings / Revenue -519.74% -93.99%
Basic Earnings Per Share -$1.88
Diluted Earnings Per Share -$1.88 -$651.8K
COMMON SHARES
Basic Shares Outstanding 6.261M shares 67.67M shares
Diluted Shares Outstanding 6.261M shares

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.26M $13.26M
YoY Change 0.0% -4.54%
Cash & Equivalents $13.26M $13.26M
Short-Term Investments
Other Short-Term Assets $530.0K $610.0K
YoY Change -13.11% 5.17%
Inventory $2.384M $3.724M
Prepaid Expenses
Receivables $3.741M $4.541M
Other Receivables $0.00 $0.00
Total Short-Term Assets $19.91M $22.13M
YoY Change -10.04% 8.48%
LONG-TERM ASSETS
Property, Plant & Equipment $1.248M $1.816M
YoY Change -31.28% -20.04%
Goodwill $189.0K $189.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $117.0K $168.0K
YoY Change -30.36% 40.0%
Total Long-Term Assets $2.439M $3.450M
YoY Change -29.3% 22.99%
TOTAL ASSETS
Total Short-Term Assets $19.91M $22.13M
Total Long-Term Assets $2.439M $3.450M
Total Assets $22.35M $25.58M
YoY Change -12.64% 10.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.902M $2.480M
YoY Change -23.31% -4.25%
Accrued Expenses $1.180M $2.768M
YoY Change -57.37% -12.46%
Deferred Revenue $1.345M $1.369M
YoY Change -1.75%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.430M $2.333M
YoY Change 4.16% 0.0%
Total Short-Term Liabilities $7.129M $9.343M
YoY Change -23.7% -0.55%
LONG-TERM LIABILITIES
Long-Term Debt $640.0K $1.535M
YoY Change -58.31% -59.02%
Other Long-Term Liabilities $29.00K $45.00K
YoY Change -35.56% 25.0%
Total Long-Term Liabilities $29.00K $1.580M
YoY Change -98.16% -58.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.129M $9.343M
Total Long-Term Liabilities $29.00K $1.580M
Total Liabilities $22.38M $20.18M
YoY Change 10.89% 29.5%
SHAREHOLDERS EQUITY
Retained Earnings -$197.6M -$180.8M
YoY Change 9.3% 12.95%
Common Stock $8.000K $75.00K
YoY Change -89.33% 22.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$28.00K $5.404M
YoY Change
Total Liabilities & Shareholders Equity $22.35M $25.58M
YoY Change -12.64% 10.23%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$11.77M -$3.066M
YoY Change 283.79% -61.57%
Depreciation, Depletion And Amortization $160.0K $240.0K
YoY Change -33.33% -47.83%
Cash From Operating Activities -$4.030M -$4.530M
YoY Change -11.04% -25.12%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$50.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$50.00K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.750M 8.600M
YoY Change 1.74% -1557.63%
NET CHANGE
Cash From Operating Activities -4.030M -4.530M
Cash From Investing Activities 0.000 -50.00K
Cash From Financing Activities 8.750M 8.600M
Net Change In Cash 4.720M 4.020M
YoY Change 17.41% -160.54%
FREE CASH FLOW
Cash From Operating Activities -$4.030M -$4.530M
Capital Expenditures $0.00 -$50.00K
Free Cash Flow -$4.030M -$4.480M
YoY Change -10.04% -25.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001549084
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.067
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P6M
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.067
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
Ekso Bionics Holdings, Inc.
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37854
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0367049
dei Entity Address Address Line1
EntityAddressAddressLine1
1414 Harbour Way South
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1201
dei Entity Address City Or Town
EntityAddressCityOrTown
Richmond
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94804
dei City Area Code
CityAreaCode
510
dei Local Phone Number
LocalPhoneNumber
984-1761
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
EKSO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8271271 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13260000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10872000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
100000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
121000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3741000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5208000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
2384000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
2489000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
525000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
238000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
19910000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
18807000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1248000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1657000 USD
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
885000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1084000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
189000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
189000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
117000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
178000 USD
CY2020Q2 us-gaap Assets
Assets
22349000 USD
CY2019Q4 us-gaap Assets
Assets
21915000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1902000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1903000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1180000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1683000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1345000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1492000 USD
CY2020Q2 us-gaap Notes Payable Current
NotesPayableCurrent
2433000 USD
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2333000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
269000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
421000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7129000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7832000 USD
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1706000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1789000 USD
CY2020Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
644000 USD
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
407000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
508000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
711000 USD
CY2020Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
12361000 USD
CY2019Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
4307000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
72000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
22377000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
15118000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7814000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7814000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5795000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5795000 shares
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
197513000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
190019000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
30000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
50000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-197579000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-183278000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-28000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
6797000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22349000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21915000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2264000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3262000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3731000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6878000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1005000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1702000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1835000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3719000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
1259000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
1560000 USD
us-gaap Gross Profit
GrossProfit
1896000 USD
us-gaap Gross Profit
GrossProfit
3159000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1712000 USD
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3039000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4232000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5848000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
452000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1499000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1163000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2883000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1943000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2120000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4130000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4438000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
244000 USD
CY2019Q2 us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Restructuring Charges
RestructuringCharges
244000 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
4351000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
6658000 USD
us-gaap Operating Expenses
OperatingExpenses
9769000 USD
us-gaap Operating Expenses
OperatingExpenses
13169000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3092000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5098000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7873000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-10010000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
38000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
107000 USD
us-gaap Interest Expense
InterestExpense
90000 USD
us-gaap Interest Expense
InterestExpense
228000 USD
CY2020Q2 ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
-8574000 USD
CY2019Q2 ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
2737000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
-6055000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
1615000 USD
CY2020Q2 ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 USD
CY2019Q2 ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 USD
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 USD
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
-257000 USD
CY2020Q2 ekso Warrant Issuance Expense
WarrantIssuanceExpense
329000 USD
CY2019Q2 ekso Warrant Issuance Expense
WarrantIssuanceExpense
706000 USD
ekso Warrant Issuance Expense
WarrantIssuanceExpense
329000 USD
CY2019Q2 ekso Other Income Expense
OtherIncomeExpense
108000 USD
ekso Other Income Expense
OtherIncomeExpense
46000 USD
ekso Warrant Issuance Expense
WarrantIssuanceExpense
706000 USD
CY2020Q2 ekso Other Income Expense
OtherIncomeExpense
266000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-193000 USD
ekso Other Income Expense
OtherIncomeExpense
-31000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8675000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2032000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6428000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
393000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11767000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-3066000 USD
us-gaap Net Income Loss
NetIncomeLoss
-14301000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9617000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-106000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-20000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
42000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11960000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3172000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14321000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9575000 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.88
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.37
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.12
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6261000 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4713000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6032000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4526000 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
6797000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-2534000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
155000 USD
CY2020Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
50000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
587000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
173000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5228000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11767000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7082000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
2728000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-6551000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7305000 USD
CY2019Q1 ekso Stock Issued During Period Value Equiposis Supply And Sales Earnouts
StockIssuedDuringPeriodValueEquiposisSupplyAndSalesEarnouts
22000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
55000 USD
CY2020Q2 ekso Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
1436000 USD
CY2020Q2 ekso Adjustments To Additional Paid In Capital Warrant Issuance
AdjustmentsToAdditionalPaidInCapitalWarrantIssuance
2322000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
508000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-193000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-28000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
191000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
636000 USD
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
148000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
4534000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-3066000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2393000 USD
us-gaap Depreciation
Depreciation
320000 USD
us-gaap Depreciation
Depreciation
493000 USD
us-gaap Inventory Write Down
InventoryWriteDown
47000 USD
CY2019Q2 ekso Stock Issued During Period Value Equiposis Supply And Sales Earnouts
StockIssuedDuringPeriodValueEquiposisSupplyAndSalesEarnouts
173000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
919000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
557000 USD
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-106000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
5404000 USD
us-gaap Net Income Loss
NetIncomeLoss
-14301000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9617000 USD
us-gaap Inventory Write Down
InventoryWriteDown
24000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
47000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
50000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
-6055000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
1615000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
329000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
706000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1095000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1193000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
23000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
55000 USD
ekso Gain Loss On Modification Of Operating Lease Liabilities
GainLossOnModificationOfOperatingLeaseLiabilities
-38000 USD
ekso Gain Loss On Modification Of Operating Lease Liabilities
GainLossOnModificationOfOperatingLeaseLiabilities
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-66000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
ekso Common Stock Contribution
CommonStockContribution
99000 USD
ekso Common Stock Contribution
CommonStockContribution
103000 USD
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 USD
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
-257000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-7000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-34000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1420000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
931000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-147000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
260000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
84000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
182000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-654000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-746000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
103000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-230000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
533000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5745000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9708000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
60000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7082000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16325000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
793000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1185000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1086000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5607000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
785000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
228000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8160000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15368000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-27000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2388000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10872000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7655000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13260000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13262000 USD
us-gaap Interest Paid Net
InterestPaidNet
61000 USD
us-gaap Interest Paid Net
InterestPaidNet
183000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
8000 USD
ekso Operating Leases Right Of Use Asset Initial Recognition
OperatingLeasesRightOfUseAssetInitialRecognition
0 USD
ekso Operating Leases Right Of Use Asset Initial Recognition
OperatingLeasesRightOfUseAssetInitialRecognition
1454000 USD
ekso Operating Leases Liability Initial Recognition
OperatingLeasesLiabilityInitialRecognition
0 USD
ekso Operating Leases Liability Initial Recognition
OperatingLeasesLiabilityInitialRecognition
1498000 USD
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
89000 USD
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
117000 USD
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
155000 USD
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
191000 USD
us-gaap Stock Issued1
StockIssued1
50000 USD
us-gaap Stock Issued1
StockIssued1
919000 USD
ekso Sales Earnout
SalesEarnout
0 USD
ekso Sales Earnout
SalesEarnout
22000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-197579000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5745000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13260000 USD
us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.35
CY2020Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
785000 USD
CY2020Q2 ekso Debt Covenant Covenant Compliance Unrestricted Cash
DebtCovenantCovenantComplianceUnrestrictedCash
1750000 USD
ekso Unrestricted Cash
UnrestrictedCash
11510000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are not limited to, revenue recognition, deferred revenue and the deferral of the associated costs, the valuation of warrants and employee stock options, future warranty costs, accounting for leases, useful lives assigned to long-lived assets, valuation of inventory, realizability of deferred tax assets, and contingencies. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-19. Actual results could differ from those estimates. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.</span></div>
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
29000 USD
CY2019Q1 us-gaap Grants Receivable
GrantsReceivable
1500000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="text-indent:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company maintains its cash accounts in excess of federally insured limits. However, the Company believes it is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. The Company extends credit to customers, most of which are hospitals or other large nationally recognizable institutions, in the normal course of business. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the condensed consolidated financial statements. The Company does not require collateral from its customers to secure accounts receivable.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Accounts receivable are derived from the sale of products shipped to and services performed for customers. Invoices are aged based on contractual terms with the customer. The Company reviews accounts receivable for collectability and records an allowance for credit losses, as needed. The Company has not experienced any material losses related to accounts receivable as of June 30, 2020 and December 31, 2019.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency. The Company does not enter into any foreign currency hedging agreements and is susceptible to gains and losses from foreign currency fluctuations. To date, the Company has not experienced significant gains or losses upon settling foreign currency denominated accounts receivable.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">At June 30, 2020, the Company had two customers with an accounts receivable balance totaling 10% or more of the Company’s total accounts receivable (10% and 17%), as compared with one customer at December 31, 2019 (11%).</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the three months ended June 30, 2020, the Company had two customers with sales of 10% or more of the Company’s total revenue (11% and 13%), as compared with one customer in the three months ended June 30, 2019 (31%).</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the six months ended June 30, 2020, the Company had no customers with sales of 10% or more of the Company’s total revenue, as compared with one customer in the six months ended June 30, 2019 (21%).</span></div>
CY2020Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.35
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
244000 USD
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2041000 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2208000 USD
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
29000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
2489000 USD
CY2020Q2 us-gaap Deferred Revenue Leases Net
DeferredRevenueLeasesNet
117000 USD
CY2019Q4 us-gaap Deferred Revenue Leases Net
DeferredRevenueLeasesNet
131000 USD
CY2020Q2 ekso Contract With Customers Liability Customer Deposits And Advances
ContractWithCustomersLiabilityCustomerDepositsAndAdvances
15000 USD
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
314000 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
252000 USD
CY2020Q2 us-gaap Inventory Net
InventoryNet
2384000 USD
CY2020Q2 ekso Deferred Extended Maintenance And Support
DeferredExtendedMaintenanceAndSupport
2634000 USD
CY2019Q4 ekso Deferred Extended Maintenance And Support
DeferredExtendedMaintenanceAndSupport
2837000 USD
CY2020Q2 ekso Deferred Royalties
DeferredRoyalties
285000 USD
CY2019Q4 ekso Deferred Royalties
DeferredRoyalties
290000 USD
CY2019Q4 ekso Contract With Customers Liability Customer Deposits And Advances
ContractWithCustomersLiabilityCustomerDepositsAndAdvances
23000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3051000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3281000 USD
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1345000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5208000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1492000 USD
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1706000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1789000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3281000 USD
ekso Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
674000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
904000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3051000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3051000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
767000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1060000 USD
CY2020Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1224000 USD
CY2020Q2 ekso Contract With Customer Liability Non Cancellable Backlog
ContractWithCustomerLiabilityNonCancellableBacklog
496000 USD
CY2020Q2 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P12M
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3741000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2264000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3731000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3262000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6878000 USD
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
746000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1098000 USD
CY2020Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
200000 USD
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
285000 USD
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
234000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
300000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1180000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1683000 USD
CY2016Q4 ekso Success Fee Expenses
SuccessFeeExpenses
250000 USD
CY2016Q4 us-gaap Share Price
SharePrice
120.00
CY2020Q2 ekso Debt Covenant Covenant Compliance Unrestricted Cash
DebtCovenantCovenantComplianceUnrestrictedCash
1750000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13260000 USD
CY2020Q2 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0805
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0880
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1458000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
537000 USD
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1995000 USD
CY2020Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
4000 USD
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
1991000 USD
CY2020Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2020Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
50000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
589000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
232000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
871000 USD
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
94000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
777000 USD
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
269000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
508000 USD
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
777000 USD
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y11M8D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7814000 shares
ekso Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
6000 shares
CY2020Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1945000 shares
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
135000 USD
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
130000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
273000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
270000 USD
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7814000 shares
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1178000 shares
ekso Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
996000 shares
ekso Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
223000 shares
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
-257000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
508000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
557000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1095000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1193000 USD
CY2020Q1 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2020Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
50000 USD
CY2020Q2 us-gaap Contractual Obligation
ContractualObligation
539000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11767000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3066000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14301000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9617000 USD
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6261000 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4713000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6032000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4526000 shares
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.88
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.37
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.12
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2647000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1009000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2647000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1009000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2264000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1005000 USD
us-gaap Gross Profit
GrossProfit
1896000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6878000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
1259000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3262000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1702000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
1560000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3731000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1835000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3719000 USD
us-gaap Gross Profit
GrossProfit
3159000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2264000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3262000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3731000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6878000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
45000 USD

Files In Submission

Name View Source Status
0001549084-20-000025-index-headers.html Edgar Link pending
0001549084-20-000025-index.html Edgar Link pending
0001549084-20-000025.txt Edgar Link pending
0001549084-20-000025-xbrl.zip Edgar Link pending
ekso-20200630.htm Edgar Link pending
ekso-20200630.xsd Edgar Link pending
ekso-20200630_cal.xml Edgar Link unprocessable
ekso-20200630_def.xml Edgar Link unprocessable
ekso-20200630_htm.xml Edgar Link completed
ekso-20200630_lab.xml Edgar Link unprocessable
ekso-20200630_pre.xml Edgar Link unprocessable
ekso-6302020xex311.htm Edgar Link pending
ekso-6302020xex312.htm Edgar Link pending
ekso-6302020xex321.htm Edgar Link pending
ekso-6302020xex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending